Supriya Lifescience Limited
Supriya Lifescience Limited, a prominent player in the pharmaceutical industry, is headquartered in India and operates extensively across various regions. Founded in 1997, the company has established itself as a leader in the production of active pharmaceutical ingredients (APIs) and intermediates, catering to both domestic and international markets. With a strong focus on quality and innovation, Supriya Lifescience offers a diverse range of products, including anti-allergic, anti-inflammatory, and anti-viral APIs. Their commitment to research and development has led to significant advancements, positioning them as a trusted supplier in the global pharmaceutical landscape. Notably, the company has achieved several milestones, including regulatory approvals from major international health authorities, further solidifying its reputation for excellence in the industry.
DitchCarbon Score
How does Supriya Lifescience Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Supriya Lifescience Limited's score of 18 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Supriya Lifescience Limited's reported carbon emissions
In 2023, Supriya Lifescience Limited reported total carbon emissions of approximately 11,450,770 kg CO2e from Scope 2 and 490,206 kg CO2e from Scope 1, resulting in a combined total of about 11,940,976 kg CO2e. This represents a slight increase in emissions compared to 2022, where the company recorded approximately 8,643,810 kg CO2e from Scope 2 and 315,257 kg CO2e from Scope 1, totalling around 8,959,067 kg CO2e. For 2024, emissions are projected to be approximately 10,995,310 kg CO2e from Scope 2 and 451,010 kg CO2e from Scope 1, indicating a continued focus on managing carbon output. Despite these figures, Supriya Lifescience has not disclosed specific reduction targets or initiatives under the Science Based Targets initiative (SBTi) or other climate pledges, suggesting a need for further commitment to climate action. The company’s emissions intensity per rupee of turnover has shown variability, with a reported value of approximately 0.0000563 kg CO2e in 2023, reflecting the relationship between revenue and emissions. As Supriya Lifescience continues to navigate its carbon footprint, the emphasis on transparency and accountability in emissions reporting will be crucial for aligning with global climate goals.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 315,257 | 000,000 | 000,000 |
| Scope 2 | 8,643,810 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Supriya Lifescience Limited is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
